Dr. Richard P. Goddeau Jr., DO

Dr. Goddeau practices at Community Neuroscience Services in Leominster, Massachusetts.

Dr. Goddeau's NPI, 1881745826, was assigned on January 16, 2007. Dr. Goddeau graduated from UNE College of Osteopathic Medicine in 2004. Dr. Goddeau holds Massachusetts license 238478.

Dr. Goddeau's primary practice is Community Neuroscience Services, at 14 Monument Sq, Leominster, MA 01453 in Worcester County. The practice phone is (508) 898-0055.

Dr. Goddeau's primary practice is Community Neuroscience Services in Leominster, Massachusetts. Dr. Goddeau is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is Community Neuroscience Services. Dmand AI also links Dr. Goddeau to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goddeau practices. Vendor and product names are available with a free account.

Neurology is Dr. Goddeau's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Goddeau is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Goddeau's licenses on file in 2 states: Massachusetts and New Hampshire.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, encephalopathy and epilepsy among the conditions Dr. Goddeau treats.

CMS data shows 59 Medicare services from Dr. Goddeau across 3 procedure codes in 2024, all of them office visits, for 78 Medicare patients. Medicare paid $4,102 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 78 Medicare patients who saw Dr. Goddeau in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goddeau's median patient age at 77, with 52% women.

In 2024, Dr. Goddeau wrote 39 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $106 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Goddeau for performance year 2024, reported through an alternative payment model (APM). Dr. Goddeau accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 47 papers to Dr. Goddeau, published from 2009 to 2019. 2014 was the busiest year, with 6. The most frequent topics are Stroke, Brain Ischemia and Leukoaraiosis. Dr. Goddeau has published most often in J Stroke Cerebrovasc Dis. Dr. Goddeau's most frequent co-authors are Nils Henninger, MD, Majaz Moonis, MD and Brian Silver, MD.

Dmand AI links Dr. Goddeau to 1 clinical trial. Conditions studied include Ischemic Stroke and Stroke.

CMS Open Payments shows 1 general payment to Dr. Goddeau from 1 drug or device company in 2024. Education make up the largest share, 100% of the total. CSL Behring paid the most, $20.

Dr. Goddeau graduated from UNE College of Osteopathic Medicine in 2004.

Dr. Goddeau is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.